Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-043219
Filing Date
2017-07-05
Accepted
2017-07-05 16:03:20
Documents
2
Period of Report
2017-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2788
2 POA DOCUMENT poa.txt EX-24.3_734578 3982
  Complete submission text file 0001209191-17-043219.txt   8116
Mailing Address 150 SECOND STREET CAMBRIDGE MA 02141
Business Address 150 SECOND STREET CAMBRIDGE MA 02141 617-418-2200
Foundation Medicine, Inc. (Issuer) CIK: 0001488613 (see all company filings)

EIN.: 271316416 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O FOUNDATION MEDICINE, INC. 150 SECOND STREET CAMBRIDGE MA 02141
Business Address
Doherty Michael J (Reporting) CIK: 0001710939 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36086 | Film No.: 17947919